← Browse by Condition
Medical Condition

rem sleep behavior disorder

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for rem sleep behavior disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — rem sleep behavior disorder Clinical Trials

How many clinical trials are currently recruiting for rem sleep behavior disorder?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for rem sleep behavior disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for rem sleep behavior disorder?
rem sleep behavior disorder research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a rem sleep behavior disorder clinical trial?
Eligibility criteria for rem sleep behavior disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
NYU Langone Health 1 trial
University of Cagliari 1 trial
University of Minnesota 1 trial

Recruiting Clinical Trials

NCT01799915
Recruiting
Natural History Study of Synucleinopathies
Enrollment
800 pts
Location
United States, Argen...
Sponsor
NYU Langone Health
View Trial →
NCT05262543
Recruiting
PREdictive Risk Factors of Conversion Into Idiopathic RBD. Italian Study
Enrollment
300 pts
Location
Italy
Sponsor
University of Cagliari
View Trial →
NCT06467461
Recruiting
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder
Enrollment
60 pts
Location
United States
Sponsor
University of Minnesota
View Trial →

Related Conditions

parkinson disease (2) dementia with lewy bodies (2) patients with synucleinopathies (1) neurogenic orthostatic hypotension (1) pure autonomic failure (1) multiple system atrophy (1) shy drager disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology